Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

Treponema Lecithinolyticum Lipopolysaccharide¿¡ ÀÇÇÑ matrix metalloproteinase-9ÀÇ ¹ßÇö

Effect of Treponema Lecithinolyticum Lipopolysaccharide on matrix metalloproteinase-9 expression

´ëÇÑÄ¡ÁÖ°úÇÐȸÁö 2005³â 35±Ç 3È£ p.675 ~ 685
¼Ò¼Ó »ó¼¼Á¤º¸
³²Á¤¾Æ ¹®¼±¿µ/ÀÌÁø¿í/Â÷Á¤Çå/ÃÖºÀ±Ô/À¯À±Á¤

Abstract


Bone resorption involves sequential stages of osteoclast precursor migration and differentiation of osteoclast precursors into multinucleated osteoclasts. Stromal cell derived factor
(SDF)-1 is a chemotactic factor for osteoclast precursor migration. Matrix metalloproteinase
(MMP)-9 is involved in migration of osteoclast precursors and activation of interleukin(IL)-1¥â.
Alveolar bone destruction is a characteristic feature of periodontal disease. Treponema
lecithinolyticum is a oral spirochete isolated from the periodontal lesions. The effect of
lipopolysaccharide(LPS) from T. lecithinolyticum on expression of SDF-1 and MMP-9 was
examined in cocultures of bone marrow cells and osteblasts derived from mouse calvariae.
T. lecithinolyticum LPS increased expression of MMP-9 in the coculture. Polymyxin B, an
inhibitor of LPS, abolished the increase of MMP-9 mRNA expression by LPS. LPS did not
increase the expression of SDF-1, IL-1¥â and tumor necrosis factor(TNF)-¥á mRNA in
cocultures. Prostaglandin E2(PGE2) up-regulated the expression of MMP-9 and NS398, an
inhibitor of PGE2 synthesis, down-regulated the induction of MMP-9 expression by T.
lecithinolyticm LPS.
These results suggest that T. lecithinolytium LPS increases MMP-9 expression in bone cells
via PGE2 and that the induction of MMP-9 expression by T. lecithinolyticum LPS is involved
in alveolar bone destruction of periodontitis patients by the increase of osteoclast precursor
migration and the activation of bone resorption-inducing cytokine.2)

Å°¿öµå

Treponema Lecithinolyticum;Lipopolysaccharide;MMP-9

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

 

µîÀçÀú³Î Á¤º¸

KCI